Peutz-Jeghers syndrome pathophysiology

Peutz-Jeghers syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Peutz-Jeghers syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Peutz-Jeghers syndrome pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Peutz-Jeghers syndrome pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Peutz-Jeghers syndrome pathophysiology
CDC on Peutz-Jeghers syndrome pathophysiology
Peutz-Jeghers syndrome pathophysiology in the news
Blogs on Peutz-Jeghers syndrome pathophysiology
Directions to Hospitals Treating Peutz-Jeghers syndrome
Risk calculators and risk factors for Peutz-Jeghers syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

Genetics

In 1998, a gene was found to be associated with the mutation. On chromosome 19, the gene known as STK11 (LKB1) is a possible tumor suppressor gene. It is inherited in an Autosomal Dominant pattern (see Mendelian inheritance) which means that anyone who has PJS has a 50% chance of passing it onto their children.

References

de:Peutz-Jeghers-Syndrom it:Sindrome di Peutz-Jeghers nl:Syndroom van Peutz-Jeghers